Drugs / Gel-Flow NT
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT05929755 Background | May 2023 → Aug 2025 overdue | myopathy, neuropathy, painful | Hardeep Singh | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gel-Flow NT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05929755 ↗ |